| Issue Date | Title | Author(s) |
| - | An Appraisal of the Current Scenario in Vaccine Research for COVID-19 | Chong, WC; Chellappan, DK; Shukla, SD; Peterson, GM; Patel, RP; Jha, NK; Eri, RD; Dua, K; Tambuwala, MM; Shastri, MD |
| 2011-03-01 | Clinical outcomes of a collaborative, home-based postdischarge warfarin management service | Stafford, L; Peterson, GM; Bereznicki, LRE; Jackson, SL; Van Tienen, EC; Angley, MT; Bajorek, BV; McLachlan, AJ; Mullan, JR; Misan, GMH; Gaetani, L |
| 2020-11-05 | Emerging concepts and directed therapeutics for the management of asthma: regulating the regulators. | Shastri, MD; Chong, WC; Dua, K; Peterson, GM; Patel, RP; Mahmood, MQ; Tambuwala, M; Chellappan, DK; Hansbro, NG; Shukla, SD; Hansbro, PM |
| 2012-04-02 | Home medicines reviews following acute coronary syndrome: Study protocol for a randomized controlled trial | Bernal, DDL; Stafford, L; Bereznicki, LRE; Castelino, RL; Davidson, PM; Peterson, GM |
| 2021-08 | Interleukin-13: A pivotal target against influenza-induced exacerbation of chronic lung diseases | Shastri, MD; Allam, VSRR; Shukla, SD; Jha, NK; Paudel, KR; Peterson, GM; Patel, RP; Hansbro, PM; Chellappan, DK; Dua, K |
| 2016-02-01 | Medication Adherence Following Acute Coronary Syndrome: Does One Size Fit All? | Bernal, DDL; Bereznicki, LRE; Chalmers, L; Castelino, RL; Thompson, A; Davidson, PM; Peterson, GM |
| 2019-06-01 | Microbiome-focused asthma management strategies | Shukla, SD; Shastri, MD; Chong, WC; Dua, K; Budden, KF; Mahmood, MQ; Hansbro, NG; Keely, S; Eri, R; Patel, RP; Peterson, GM; Hansbro, PM |
| 2018-01-01 | Role of oxidative stress in the pathology and management of human tuberculosis | Shastri, MD; Shukla, SD; Chong, WC; Dua, K; Peterson, GM; Patel, RP; Hansbro, PM; Eri, R; O'Toole, RF |
| 2021-01-01 | Smoking and COVID-19: What we know so far. | Shastri, MD; Shukla, SD; Chong, WC; Kc, R; Dua, K; Patel, RP; Peterson, GM; O'Toole, RF |
| 2021-01 | The complex interplay between endoplasmic reticulum stress and the NLRP3 inflammasome: a potential therapeutic target for inflammatory disorders. | Chong, WC; Shastri, MD; Peterson, GM; Patel, RP; Pathinayake, PS; Dua, K; Hansbro, NG; Hsu, AC; Wark, PA; Shukla, SD; Johansen, MD; Schroder, K; Hansbro, PM |
| 2012-08-01 | Warfarin management after discharge from hospital: A qualitative analysis | Stafford, L; Van Tienen, EC; Peterson, GM; Bereznicki, LRE; Jackson, SL; Bajorek, BV; Mullan, JR; DeBoos, IM |
